Clarus Therapeutics Holdings Inc

NASDAQ:CRXT 1:54:27 PM EDT

0.40

+0.02 (+4.64%)

Market Cap (Intraday)	20.66M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.97 Million
Adjusted EPS	-$0.29

See more estimates

10-Day MA	$0.43
50-Day MA	$0.98
200-Day MA	N/A

See more pivots

Clarus Therapeutics Holdings Inc Stock, NASDAQ:CRXT

555 Skokie Boulevard, Suite 340, Northbrook, Illinois 60062

United States of America

Phone: +1.847.562.4300

Number of Employees:

http://clarustherapeutics.com

Description

Clarus Therapeutics Holdings, Inc. is a pharmaceutical company, which engages in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications. The company was founded in 2004 and is headquartered in Northbrook, IL.